glp 1 patents Lilly new GLP-1R agonists The Lancet argued that 2026
Description
Sign up for free today.
Buonanno, S
Recent medical research, including a study published in JAMA Ophthalmology, found that patients prescribed semaglutide (Ozempic, Wegovy) experienced NAION at a rate over 7 times higher than those on other medications
That means it works by stimulating release of not one, but two unique incretin hormones produced by the human body
These findings underscore the need for more longer-term, higher-quality studies
Low-Intensity Pulsed Ultrasound Counteracts Advanced Glycation End Products-Induced Corpus Cavernosal Endothelial Cell Dysfunction via Activating Mitophagy
